Skip to content
healthcare.dev

Oratox

NDC 43742-0944, Fucus Vesiculosus, Lymph Node (Suis), Medulla Ossis Suis, Thymus (Suis), Thyroidinum (Suis), Calcarea Muriatica, Iodium, Natrum Fluoratum, Natrum Muriaticum, Selenium Metallicum, Vanadium Metallicum, Argentum Metallicum, Aurum Metallicum, Cuprum Metallicum, Eugenol, Formalinum, Lidocaine, Mercurius Solubilis, Molybdenum Metallicum, Niccolum Metallicum, Palladium Metallicum, Stannum Metallicum, Titanium Metallicum, Zincum Metallicum, liquid, from Deseret Biologicals, Inc..

Product NDC
43742-0944
Status
Listed
Labeler
Deseret Biologicals, Inc.
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43742-0944 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FUCUS VESICULOSUS3 [hp_X]/mL
  • SUS SCROFA LYMPH8 [hp_X]/mL
  • SUS SCROFA BONE MARROW8 [hp_X]/mL
  • SUS SCROFA THYMUS8 [hp_X]/mL
  • THYROID8 [hp_X]/mL
  • CALCIUM CHLORIDE12 [hp_X]/mL
  • IODINE12 [hp_X]/mL
  • SODIUM FLUORIDE12 [hp_X]/mL
  • SODIUM CHLORIDE12 [hp_X]/mL
  • SELENIUM12 [hp_X]/mL
  • VANADIUM12 [hp_X]/mL
  • SILVER12 [hp_X]/mL
  • GOLD12 [hp_X]/mL
  • COPPER12 [hp_X]/mL
  • EUGENOL12 [hp_X]/mL
  • FORMALDEHYDE12 [hp_X]/mL
  • LIDOCAINE12 [hp_X]/mL
  • MERCURIUS SOLUBILIS12 [hp_X]/mL
  • MOLYBDENUM12 [hp_X]/mL
  • NICKEL12 [hp_X]/mL
  • PALLADIUM12 [hp_X]/mL
  • TIN12 [hp_X]/mL
  • TITANIUM12 [hp_X]/mL
  • ZINC12 [hp_X]/mL

Pharmacologic classes

Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]; Blood Coagulation Factor [EPC]; Calcium [CS]; Cations, Divalent [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Copper [CS]; Copper-containing Intrauterine Device [EPC]; Decreased Embryonic Implantation [PE]; Decreased Sperm Motility [PE]; Increased Coagulation Factor Activity [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Inhibit Ovum Fertilization [PE]; Local Anesthesia [PE]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Standardized Chemical Allergen [EPC]; Standardized Chemical Allergen [EPC]; Standardized Chemical Allergen [EPC]; Standardized Chemical Allergen [EPC]

Package NDCNDC-11Package
43742-0944-14374209440130 mL in 1 BOTTLE, DROPPER (43742-0944-1)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 43742-0944 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43742-0944 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43742-0944. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.